Published in Gut on June 01, 2001
A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights (2007) 2.39
Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut (2003) 1.77
Genomic and genetic alterations influence the progression of gastric cancer. World J Gastroenterol (2011) 1.55
Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol (2002) 1.25
Soluble cadherins as cancer biomarkers. Clin Exp Metastasis (2007) 1.20
Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol (2011) 1.18
E-cadherin in gastric cancer. World J Gastroenterol (2006) 1.11
Stem cells in gastric cancer. World J Gastroenterol (2015) 0.96
Soluble E-cadherin: more than a symptom of disease. Front Biosci (Landmark Ed) (2012) 0.95
Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients. Clin Exp Metastasis (2004) 0.94
E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res Int (2014) 0.92
Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer. Br J Cancer (2005) 0.90
Effect of P-selectin monoclonal antibody on metastasis of gastric cancer and immune function. World J Gastroenterol (2003) 0.86
Helicobacter pylori activates calpain via toll-like receptor 2 to disrupt adherens junctions in human gastric epithelial cells. Infect Immun (2011) 0.83
Soluble E-cadherin: an early marker of severity in acute pancreatitis. HPB Surg (2009) 0.83
Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes (2013) 0.82
A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer. Mol Cancer (2015) 0.81
Cleavage of transmembrane junction proteins and their role in regulating epithelial homeostasis. Tissue Barriers (2013) 0.81
CDH1 germline mutation in hereditary gastric carcinoma. World J Gastroenterol (2004) 0.80
Genes Regulating Epithelial Polarity Are Critical Suppressors of Esophageal Oncogenesis. J Cancer (2015) 0.79
Increased SNAIL expression and low syndecan levels are associated with high Gleason grade in prostate cancer. Int J Oncol (2014) 0.79
Alpha-catenin expression is decreased in patients with gastric carcinoma. World J Gastroenterol (2005) 0.79
How echinoccocosis affects potential cancer markers in plasma: galectin-3, sN-cadherin and sE-cadherin? A preliminary report. Diagn Pathol (2012) 0.79
Levels of soluble E-cadherin in breast, gastric, and colorectal cancers. Biomed Res Int (2014) 0.78
Effects of c9,t11-conjugated linoleic acid on adhesion of human gastric carcinoma cell line SGC-7901. World J Gastroenterol (2004) 0.75
Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors. BMC Cancer (2013) 0.75
The extracellular domain of E cadherin linked to invasiveness in colorectal cancer: a new resistance and relapses monitoring serum-bio marker? J Cancer Res Clin Oncol (2017) 0.75
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65
The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development (1988) 8.84
Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell (1991) 8.75
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol (1991) 8.60
Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol (1989) 6.31
Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta (1994) 5.81
Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol (1993) 5.22
Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem (1987) 3.17
Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol (1993) 2.84
Expression of E- and P-cadherin in gastric carcinomas. Cancer Res (1991) 2.56
E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res (1993) 2.55
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res (1994) 2.34
Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res (1993) 2.09
E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol (1993) 1.89
Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol (1996) 1.86
Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol (1994) 1.51
Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer (1996) 1.40
Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer (1994) 1.36
Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol (1997) 1.35
Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer (1997) 1.25
E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer (1995) 1.25
Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver. Gastroenterology (1996) 1.07
Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. Br J Cancer (1996) 1.03
Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virchows Arch (1995) 1.02
Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer (1998) 1.01
Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum Mol Genet (1993) 1.01
Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer. Br J Cancer (1997) 0.96
Characterization of soluble E-cadherin as a disease marker in gastric cancer patients. Br J Cancer (1998) 0.93
Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome. Br J Anaesth (1996) 0.90
Soluble E-cadherin: a novel cutaneous disease marker. Br J Dermatol (1995) 0.86
Roles of E- and P-cadherin in the human skin. Microsc Res Tech (1997) 0.85
Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. Br J Cancer (1995) 0.84
E- and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer. J Dermatol Sci (1996) 0.83
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science (1999) 7.66
NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell (1998) 7.58
Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med (1993) 5.84
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science (2001) 5.25
Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J (2000) 5.22
Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (1999) 5.14
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell (1999) 4.65
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Identification and characterization of variable-number tandem repeats in the Yersinia pestis genome. J Clin Microbiol (2001) 4.08
Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology (1987) 3.65
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology (2000) 3.58
Sensory transduction in bacterial chemotaxis involves phosphotransfer between Che proteins. Biochem Biophys Res Commun (1988) 3.55
Foreign body aspiration into the lower airway in Chinese adults. Chest (1997) 3.54
Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43
Fatal enterovirus 71 encephalomyelitis. J Pediatr (1998) 3.39
Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol (2000) 3.39
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
A prospective study on fish bone ingestion. Experience of 358 patients. Ann Surg (1990) 3.19
Asia Pacific consensus recommendations for colorectal cancer screening. Gut (2008) 3.19
Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med (2000) 3.12
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Francisella tularensis strain typing using multiple-locus, variable-number tandem repeat analysis. J Clin Microbiol (2001) 2.99
Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94
A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 2.93
Emerging viral diseases of Southeast Asia and the Western Pacific. Emerg Infect Dis (2001) 2.91
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology (2001) 2.72
Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia. Circ Res (2001) 2.55
Compliance with postoperative instructions: a telephone survey of 750 day surgery patients. Anaesthesia (2001) 2.53
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology (2001) 2.51
Mismatch repair co-opted by hypermutation. Science (1998) 2.49
Dengue encephalitis: a true entity? Am J Trop Med Hyg (1996) 2.49
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res (1999) 2.40
Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg (1995) 2.37
alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol (2000) 2.36
Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther (2003) 2.30
The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect (2001) 2.30
Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology (2000) 2.26
Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22
A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J Immunol (1981) 2.20
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology (1989) 2.20
HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene (2007) 2.19
Effects of the intermittent Pringle manoeuvre on hepatic gene expression and ultrastructure in a randomized clinical study. Br J Surg (2003) 2.19
Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15
Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci U S A (2000) 2.13
Nipah virus: vaccination and passive protection studies in a hamster model. J Virol (2004) 2.09
Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg (1997) 2.09
Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study. Aliment Pharmacol Ther (2014) 2.06
Gastric acid secretion is abnormally sensitive to endogenous gastrin released after peptone test meals in duodenal ulcer patients. J Clin Invest (1980) 2.03
Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther (2015) 2.03
Distribution and molecular analysis of Lyme disease spirochetes, Borrelia burgdorferi, isolated from ticks throughout California. J Clin Microbiol (1993) 2.03
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
Cilia with defective radial spokes: a cause of human respiratory disease. N Engl J Med (1979) 2.01
Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1. J Immunol (1977) 2.00
A prospective study of operative risk factors in perforated duodenal ulcers. Ann Surg (1982) 2.00
Two cases of acrometastasis to the hands and review of the literature. Curr Oncol (2008) 2.00
The Shatin community mental health survey in Hong Kong. II. Major findings. Arch Gen Psychiatry (1993) 1.99
Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathologic features. Cancer (1993) 1.99
Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg (1996) 1.97
Analysis of reduced death and complication rates after esophageal resection. Ann Surg (2001) 1.96
Adaptive radiation therapy. Phys Med Biol (1997) 1.94
Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93
Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med (1994) 1.93
Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg (1996) 1.92
Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg (2003) 1.88
Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol (2001) 1.87
Changing patterns of strabismus: a decade of experience in Hong Kong. Br J Ophthalmol (2002) 1.86
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg (1997) 1.86
Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83
Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol (2000) 1.83
Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut (2002) 1.82
Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study. Gastroenterology (1979) 1.81
Outcomes of adults hospitalised with severe influenza. Thorax (2010) 1.80
Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg (1997) 1.78
Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies. Cancer (1995) 1.77